Alerts will be sent to your verified email
Verify EmailGENNEX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.
Gennex Lab major competitors are Medico Remedies, Zim Laboratories, Trident Lifeline, Lyka Labs, Brooks Laboratories, Albert David, Medicamen Biotech.
Market Cap of Gennex Lab is ₹399 Crs.
While the median market cap of its peers are ₹358 Crs.
Gennex Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.